OTC : KKPCF

Kaken Pharmaceutical Co., Ltd.

$26 USD

$0 (0.0%)

Volume
2
Average Volume
1.8
Market Capitalization
$984.58M
P/E Ratio
68.23
Dividend Yield
4.92%
Price Target
Year High
$28.12
Year Low
$22.30
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.52
Company Overview

OTC

Hiroyuki Horiuchi

Drug Manufacturers - Specialty & Generic

Healthcare

KKPCF

1114

JP

USD

https://www.kaken.co.jp

81 3 5977 5001

N/A

N/A

Liquidity Metrics

0.03

4.52

3.60

2.15

0.00

Sales & Valuation

$77.35B

1.90

0.99

0.00

0.00

Profitability

$57.52

$2.16B

2.79%

3.01%

1.46%

1.20%

P/E Metrics

68.23

-0.41

-0.41

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Poll Results

About Kaken Pharmaceutical Co., Ltd. (OTC:KKPCF) Stock

Kaken Pharmaceutical Co., Ltd., a Tokyo-based company established in 1917, operates globally, specializing in the development, manufacture, and commercialization of a diverse array of medical products, medical devices, and agrochemicals. Its comprehensive portfolio spans various therapeutic areas. Key pharmaceutical offerings include Clenafin, a topical solution for onychomycosis; Artz, an anti-osteoarthritis medication; Seprafilm, an absorbable adhesion barrier used on damaged tissue; Fiblast, a spray designed for treating pressure and other skin ulcers; Regroth, a product aiding periodontal regeneration; and Hernicore, used for lumbar disc herniation. Other notable pharmaceutical products include Adofeed and Loxoprofen Na Tape, both pain- and inflammation-relieving plasters; Ebrantil, ad ... dressing dysuria and hypertension; Procylin, an oral prostaglandin I2 analog; Lipidil, an anti-hyperlipidemia agent; Mentax, an anti-trichophyton agent; and Ropion, an injectable pain reliever. Beyond human medicine, Kaken supplies a range of agrochemicals and animal health solutions. These include Polyoxins, a fungicide; Pentoxazone, a herbicide for rice; and Salinomycin, an anti-coccidial feed additive for poultry. The company also maintains an active research and development pipeline. Promising candidates currently under development include BBI-4000, which has completed Phase III trials for primary axillary hyperhidrosis; KMW-1, also in Phase III for the removal of eschar from thermal burns; KAR, aimed at treating hide lice infestation; and KP-607, presently in Phase II for onychomycosis. Interestingly, its operations also extend to real estate, with involvement in the rental management of Bunkyo Green Court, a commercial complex. Its products are marketed under well-known brands such as Mentax Lotrimin Ultra, Mentax Butena, Mentax, Kaifen, Fiblast, and Jublia. Strategic partnerships include license agreements with Corbus Pharmaceuticals Holdings, Inc. and Arbor Pharmaceuticals, LLC.

Frequently Asked Questions

What is the current Kaken Pharmaceutical Co., Ltd. (KKPCF) stock price?

Kaken Pharmaceutical Co., Ltd.(OTC:KKPCF) stock price is $26 in the last trading session. During the trading session, KKPCF stock reached the peak price of $28.121 while $22.3 was the lowest point it dropped to. The percentage change in KKPCF stock occurred in the recent session was 0.0% while the dollar amount for the price change in KKPCF stock was $0.

KKPCF's industry and sector of operation?

The OTC listed KKPCF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of KKPCF?

Hideki Kawabata | Head of Clinical Development Department
Keizo Kimura | Corporate Officer, Chief Officer of Production Division & Chief of Shizuoka Factory
Masashi Suzudo | MD, Director of the Corporate Planning & Coordination Department and Director
Tomoyuki Koseki | Chief Officer of Marketing & Sales Division
Gaku Kametsu | General Manager of Corporate Communications Department

How many employees does KKPCF have?

Number of KKPCF employees currently stands at 1114. KKPCF operates from 28-8, Honkomagome 2-chome, Tokyo, TY 113-8650, JP.

Link for KKPCF official website?

Official Website of KKPCF is: https://www.kaken.co.jp

How do I contact KKPCF?

KKPCF could be contacted at phone #81 3 5977 5001 and can also be accessed through its website. KKPCF operates from 28-8, Honkomagome 2-chome, Tokyo, TY 113-8650, JP.

How many shares of KKPCF are traded daily?

The average number of KKPCF shares traded daily for last 3 months was 1.8.

What is the market cap of KKPCF currently?

The market value of KKPCF currently stands at $984.58M with its latest stock price at $26